Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Identifying rare variants with optimal depth of coverage and cost-effective overlapping pool sequencing.

Investigation of rare and low-frequency variants using high-throughput sequencing with pooled DNA samples

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

Extending Rare-Variant Testing Strategies: Analysis of Noncoding Sequence and Imputed Genotypes

Integrative Analysis of Sequencing and Array Genotype Data for Discovering Disease Associations with Rare Mutations

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Rare Variants Analysis by Risk-Based Variable-Threshold Method

Low-coverage Sequencing: Implications for Design of Complex Trait Association Studies.

Biases and errors on allele frequency estimation and disease association tests of next-generation sequencing of pooled samples.

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Improved Detection of Rare Genetic Variants for Diseases

An improved burden-test pipeline for identifying associations from rare germline and somatic variants

[Family-Based Association Tests for Rare Variants].

A Robust Model-free Approach for Rare Variants Association Studies Incorporating Gene-Gene and Gene-Environmental Interactions

A Novel Efficient Algorithm for Common Variants Genotyping from Low-Coverage Sequencing Data

Pooled Association Tests for Rare Genetic Variants: A Review and Some New Results

An Expanded Association Approach for Rare Germline Variants with Copy-Number Alternation.

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases

Identifying rare variants using a Bayesian regression approach

Detecting multiple variants associated with disease based on sequencing data of case–parent trios

A Probabilistic Method for Identifying Rare Variants Underlying Complex Traits